AxoGen Inc (AXGN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:AxoGen Inc (AXGN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6562
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company offers products such as AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among others. It also offers clinical research studies in understanding and outcome of peripheral nerve regeneration and reconstruction projects. AxoGen’s clinical research programs comprise the CHANGE study, the RANGER study, and the RECON study programs. The company provide regulations for human tissue products and medical devices. It operates distribution centers in Burleson. AxoGen is headquartered in Alachua, Florida, the US.

AxoGen Inc (AXGN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AxoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AxoGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AxoGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AxoGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
AxoGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AxoGen Inc, Medical Equipment, Deal Details 10
Equity Offering 10
AxoGen Raises USD141.4 Million in Public Offering of Shares 10
AxoGen Raises USD41 Million in Public Offering of Shares 12
AxoGen Plans to Raise up to USD92.2 Million in Public Offering of Shares 14
AxoGen Raises USD20 Million in Public Offering of Shares 15
AxoGen Raises USD17.5 Million in Private Placement of Shares 17
AxoGen Raises USD15 Million in Public Offering of Shares 19
AxoGen Completes Underwriters’ Exercise Of Partial Over-Alotment Option Of Public Offering Of Shares For US$18.6 Million 20
AxoGen Completes Second Tranche Of Private Placement For US$19 Million 21
AxoGen Inc – Key Competitors 22
AxoGen Inc – Key Employees 23
AxoGen Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 01, 2018: AxoGen reports 2018 second quarter financial results 25
Apr 30, 2018: AxoGen Announces 2018 First Quarter Financial Results 27
Feb 28, 2018: AxoGen Reports 2017 Fourth Quarter and Full Year Financial Results 28
Jan 08, 2018: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue 30
Nov 01, 2017: AxoGen Reports 2017 Third Quarter Financial Results 31
Aug 02, 2017: AxoGen Reports 2017 Second Quarter Financial Results 32
May 04, 2017: AxoGen Reports 2017 First Quarter Financial Results 33
Feb 22, 2017: AxoGen Reports 2016 Fourth Quarter and Full Year Financial Results 34
Jan 09, 2017: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2016 Revenue 36
Corporate Communications 37
Jul 10, 2018: AxoGen Names Lisa N. Colleran As Board Director 37
Jun 04, 2018: AxoGen Names Kaila Krum Vice President, Investor Relations and Corporate Development 38
May 21, 2018: AxoGen Names Karen Zaderej As Board Chairman 39
Oct 18, 2017: AxoGen Receives David J. Gury Company of the Year Award from BioFlorida 40
Jul 17, 2017: AxoGen Appoints Jon Gingrich Chief Commercial Officer 41
Jan 05, 2017: AxoGen Appoints Ivica Ducic Medical Director 42
Product News 43
Nov 20, 2017: AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day 43
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
AxoGen Inc, Medical Equipment, Key Facts, 2017 2
AxoGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
AxoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AxoGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AxoGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AxoGen Inc, Deals By Market, 2012 to YTD 2018 8
AxoGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AxoGen Raises USD141.4 Million in Public Offering of Shares 10
AxoGen Raises USD41 Million in Public Offering of Shares 12
AxoGen Plans to Raise up to USD92.2 Million in Public Offering of Shares 14
AxoGen Raises USD20 Million in Public Offering of Shares 15
AxoGen Raises USD17.5 Million in Private Placement of Shares 17
AxoGen Raises USD15 Million in Public Offering of Shares 19
AxoGen Completes Underwriters’ Exercise Of Partial Over-Alotment Option Of Public Offering Of Shares For US$18.6 Million 20
AxoGen Completes Second Tranche Of Private Placement For US$19 Million 21
AxoGen Inc, Key Competitors 22
AxoGen Inc, Key Employees 23
AxoGen Inc, Other Locations 24
AxoGen Inc, Subsidiaries 24

List of Figures
AxoGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
AxoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
AxoGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
AxoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AxoGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
AxoGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AxoGen Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[AxoGen Inc (AXGN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Swietelsky Baugesellschaft mbH:企業の戦略的SWOT分析
    Swietelsky Baugesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • MYOS RENS Technology Inc (MYOS):企業の財務・戦略的SWOT分析
    Summary MYOS RENS Technology Inc (MYOS RENS), formerly MYOS Corp is a bionutrition and biotherapeutics company that discovers, develops and commercializes products that improve muscle health and function. The company offers fortetropin, a unique bioactive composition derived from fertilized chicken …
  • Global Imaging Systems, Inc.:企業のM&A・事業提携・投資動向
    Global Imaging Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Global Imaging Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • BoneSupport AB:企業の戦略的SWOT分析
    BoneSupport AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Thames Water Utilities Ltd:企業の戦略・SWOT・財務情報
    Thames Water Utilities Ltd - Strategy, SWOT and Corporate Finance Report Summary Thames Water Utilities Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Phatra Leasing Public Company Limited (PL):企業の財務・戦略的SWOT分析
    Phatra Leasing Public Company Limited (PL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • World Reach Limited (WRR):企業の財務・戦略的SWOT分析
    World Reach Limited (WRR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Theravasc Inc-製薬・医療分野:企業M&A・提携分析
    Summary Theravasc Inc (Theravasc) is a healthcare services provider that develops treatments for various chronic medical diseases using oral formulation of sodium nitrite. The company’s product TV1001SR is a coated oral formulation of sodium nitrite for the treatment of peripheral artery diseases an …
  • Permian Basin Royalty Trust (PBT):企業の財務・戦略的SWOT分析
    Summary Permian Basin Royalty Trust (Permian Basin Royalty) is an oil and gas company that owns overriding royalty rights in mineral properties in the US. The company provides oil and gas products. It has assets comprises of 75 percent net overriding royalty interest in the Waddell Ranch Properties …
  • Telecom Plus plc (TEP)-エネルギー分野:企業M&A・提携分析
    Summary Telecom Plus plc (Telecom Plus), trading as The Utility Warehouse, is a provider of utility services. The company provides diversified utility services, including fixed and mobile telephony, gas, electricity, cashback card services and broadband services. It provides benefit of single monthl …
  • NTN Corp (6472):企業の財務・戦略的SWOT分析
    NTN Corp (6472) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • C.H. Robinson Worldwide, Inc.:企業の戦略・SWOT・財務分析
    C.H. Robinson Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary C.H. Robinson Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • BBVA Banco Frances S.A. (FRAN3):企業の財務・戦略的SWOT分析
    BBVA Banco Frances S.A. (FRAN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Tokyo Gas Co Ltd (9531)-エネルギー分野:企業M&A・提携分析
    Summary Tokyo Gas Co Ltd (Tokyo Gas) is a gas utility that produces, supplies and markets liquefied natural gas (LNG). It also produces, supplies and sells electricity. Tokyo Gas also has overseas upstream, midstream and downstream businesses. It provides engineering solutions, gas appliances and ga …
  • SAS Institute Inc.:戦略・SWOT・企業財務分析
    SAS Institute Inc. - Strategy, SWOT and Corporate Finance Report Summary SAS Institute Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Daiwa Securities Group Inc:企業のM&A・事業提携・投資動向
    Daiwa Securities Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Daiwa Securities Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ):製薬・医療:M&Aディール及び事業提携情報
    Summary Eckert & Ziegler Strahlen- und Medizintechnik AG (Eckert & Ziegler) is a medical device company that offers isotope technology products. The company offers radiation therapy, isotope and radio-pharma products. It provides radiation therapy products for Brachytherapy, a minimally invasive pro …
  • Zhejiang Sunflower Light Energy Science & Technology LLC (300111):電力:M&Aディール及び事業提携情報
    Summary Zhejiang Sunflower Light Energy Science & Technology LLC (Sunowe Solar) is an alternative energy company that produces and sells solar energy battery and components. The company’s products include polycrystalline silicon wafer, photovoltaic modules, and photovoltaic cells. Its photovoltaic c …
  • Advanced Info Service Public Co Ltd (ADVANC):企業の財務・戦略的SWOT分析
    Advanced Info Service Public Co Ltd (ADVANC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Chongqing Zhifei Biological Products Co Ltd (300122):製薬・医療:M&Aディール及び事業提携情報
    Summary Chongqing Zhifei Biological Products Co Ltd (Zhifei) is a vaccine manufacturer. The company offers HibACon, MeningACon, menwayc, mycobacterium vaccae, haemophilus influenzae type b conjugate vaccine and hepatitis A (live) vaccine, freeze-dried. It research, develops, produces and markets vac …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆